EUVIMEDEUVIMED entdecken
Crossref

Experimental Design-Assisted HPTLC Method for Nirmatrelvir and Ritonavir Analysis in Pharmaceutical Dosage Forms

Ratna Musale, Hiralben Mehta, Anas Jamsa, Dilsar Gohil, Pooja Uttekar

International Journal of Drug Delivery Technology · 21.01.2026 · 16 (01)

DOI: 10.25258/ijddt.16.1.48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 21.01.2026. Verfasst von Ratna Musale und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to develop and validate a High-Performance Thin Layer Chromatography (HPTLC) method utilizing a Design of Experiments (DOE) approach for simultaneous quantification of Nirmatrelvir (NIR) and Ritonavir (RITO) in pharmaceutical dosage forms.

Method

Pre-coated HPTLC aluminium plates with silica gel 60 F254 were employed as the stationary phase to optimize the mobile phase composition. Fractional factorial design (FFD) was applied to assess method robustness. The analytical procedure was validated following ICH Q2 (R2) guidelines.

Results

Detection was carried out at 260 nm for both NIR and RITO. Optimal separation was achieved using a mobile phase of ethyl acetate, n-hexane, and methanol in a ratio of 8:1.2:0.8 v/v/v. The Rf values observed were 0.46 for NIR and 0.78 for RITO. The method was validated for multiple parameters, with %RSD values falling within acceptable limits. FFD results indicated that all four factors significantly influenced the retention of NIR, whereas RITO was not significantly affected.

Conclusion

The developed HPTLC method is simple, rapid, selective, accurate, and precise. Statistical evaluation demonstrates reproducibility with no significant differences, indicating suitability for routine analysis of marketed formulations without prior separation

Zitieren

APA

Musale, R., Mehta, H., Jamsa, A., Gohil, D., & Uttekar, P. (2026). Experimental Design-Assisted HPTLC Method for Nirmatrelvir and Ritonavir Analysis in Pharmaceutical Dosage Forms. International Journal of Drug Delivery Technology, 16(01). https://doi.org/10.25258/ijddt.16.1.48

Vancouver

Musale R, Mehta H, Jamsa A, Gohil D, Uttekar P. Experimental Design-Assisted HPTLC Method for Nirmatrelvir and Ritonavir Analysis in Pharmaceutical Dosage Forms. International Journal of Drug Delivery Technology. 2026;16(01). doi:10.25258/ijddt.16.1.48

BibTeX
@article{Musale2026,
  author = {Musale, Ratna and Mehta, Hiralben and Jamsa, Anas and Gohil, Dilsar and Uttekar, Pooja},
  title = {Experimental Design-Assisted HPTLC Method for Nirmatrelvir and Ritonavir Analysis in Pharmaceutical Dosage Forms},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {01},
  doi = {10.25258/ijddt.16.1.48}
}
Kostenlos starten →